Nkarta, Inc.
NKTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787400
No open-market purchases or sales by Nkarta, Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Nkarta, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- −7 vs. Q1 2025
- Shares held
- 58.4M
- −3.17M (−5.2%) vs. Q1 2025
- Total value
- $96.9M
- −$16.3M (−14.4%) vs. Q1 2025
- New holders
- 8
- 38 more added
- Sold out
- 15
- 32 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NKTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $167.9M |
| Q1 2026 | 126 | $121.6M |
| Q4 2025 | 119 | $103.2M |
| Q3 2025 | 120 | $119.4M |
| Q2 2025 | 104 | $96.9M |
| Q1 2025 | 111 | $113.2M |
| Q4 2024 | 112 | $154.8M |
| Q3 2024 | 119 | $301.7M |
| Q2 2024 | 112 | $391.5M |
| Q1 2024 | 115 | $687.1M |
| Q4 2023 | 94 | $270.2M |
| Q3 2023 | 85 | $50.7M |
| Q2 2023 | 97 | $86.5M |
| Q1 2023 | 100 | $147.0M |
| Q4 2022 | 121 | $251.9M |
| Q3 2022 | 105 | $561.5M |
| Q2 2022 | 115 | $536.7M |
| Q1 2022 | 84 | $287.2M |
| Q4 2021 | 92 | $366.5M |
| Q3 2021 | 87 | $651.4M |
| Q2 2021 | 89 | $764.7M |
| Q1 2021 | 97 | $866.8M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Nkarta, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Samsara BioCapital, LLC | 3,768,035 | $6.25M | 1.28% | 00.0% | Unchanged |
| BlackRock, Inc. | 4,153,845 | $6.90M | 0.00% | −375,571−8.3% | Reduced |
| Tang Capital Management LLC | 7,055,576 | $11.7M | 0.59% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 10,805,129 | $17.9M | 0.30% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −821,400−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −603,042−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −134,286−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −41,353−100.0% | Sold out |
| Standard Life Aberdeen plc | 0 | $0 | 0.00% | −28,988−100.0% | Sold out |
| Keel Point, LLC | 0 | $0 | 0.00% | −26,403−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −25,922−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −23,925−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −21,151−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −20,189−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −15,606−100.0% | Sold out |
| CIBC World Markets Corp | 0 | $0 | 0.00% | −11,741−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −5,408−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −3,834−100.0% | Sold out |